NEW YORK, Oct. 9 (GenomeWeb News) - Massachusetts General Hospital and CytRx try to use RNAi technology to develop a drug to prevent and cure amyotrophic lateral sclerosis, the groups said today.
   
The agreement comes on the heels of an RNAi-based research program CytRx penned with the University of Massachusetts Medical School - from which the company recently acquired an exclusive licenses to the RNAi technology.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

In Science this week: gut microbiome influences liver cancer growth, spread; and more.